Provided by Tiger Trade Technology Pte. Ltd.

Aligos Therapeutics, Inc.

5.03
-0.1950-3.74%
Volume:9K
Turnover:46.64K
Market Cap:31.38M
PE:-0.69
High:5.19
Open:5.17
Low:5.02
Close:5.22
52wk High:13.69
52wk Low:3.98
Shares:6.24M
Float Shares:3.70M
Volume Ratio:0.73
T/O Rate:0.25%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-7.3016
EPS(LYR):-2.4500
ROE:-113.59%
ROA:-49.12%
PB:0.98
PE(LYR):-2.05

Loading ...

Mar 09, 2023

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 09, 2023

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
Feb 14, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 14, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 13, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 08, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Dec 27, 2022

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Dec 22, 2022

Correspondence

CORRESP [Cover] - Correspondence
Nov 02, 2022

Major Issues Report

8-K - Current report
Nov 02, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 04, 2022

Major Issues Report

8-K - Current report
Aug 04, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Jun 27, 2022

Major Issues Report

8-K - Current report
May 04, 2022

Major Issues Report

8-K - Current report
May 04, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Mar 30, 2022

Major Issues Report

8-K - Current report
Mar 22, 2022

Major Issues Report

8-K - Current report
Mar 10, 2022

Major Issues Report

8-K - Current report
Mar 10, 2022

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 10, 2022

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans